[TITLE]MedaSync announces strategic investment from Omega Healthcare OHI:
[TEXT]
Mon AS X AS Amer Sports

Block Trade

Managers: Morgan Stanley

Priced at: $39.90

4.05M Shares

Special Comments

Exclusive Analysis Locked Proprietary deal commentary available to members only.
[Source link]: https://thefly.com/permalinks/entry.php/id4189228/OHI-MedaSync-announces-strategic-investment-from-Omega-Healthcare


[TITLE]SCWorx Expands Healthcare Data Management Network with New Collaboration:
[TEXT]
Tampa, FL, Aug. 26, 2025 (GLOBE NEWSWIRE) -- SCWorx Corp. (Nasdaq: WORX) today announced a new agreement with a leading healthcare supply chain partner, further strengthening its SaaS data management program.

The partner is a recognized leader in healthcare supply chain consulting, with deep experience helping hospitals unlock cost savings and optimize spend management. The partner also has access to best-in-class products and services at the local, regional, and national levels for virtually every product or service to help hospitals optimize their direct and indirect procurement spend categories.

“This partner drives measurable savings by vetting vendors, analyzing contracts, and leveraging billions in spend through strategic purchasing. They have purchasing partners in all 50 states and are growing every day. All of this helps the partner anticipate, identify, and proactively deliver cost-saving opportunities through cooperative purchasing on an ongoing basis,” said Tim Hannibal, SCWorx CEO. Hannibal added, “The SCWorx Foundation product will help this partner enhance their product line and provide additional value to their healthcare customer. This partner chose SCWorx for its data cleanse, normalization and enrichment service offerings. SCWorx is a valuable data management service partner specifically built to help hospitals in the U.S. better utilize data. This partnership reinforces the unique value SCWorx delivers to hospitals nationwide.”
[Source link]: https://www.globenewswire.com/news-release/2025/08/26/3139426/0/en/SCWorx-Expands-Healthcare-Data-Management-Network-with-New-Collaboration.html


[TITLE]Telix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference:
[TEXT]
MELBOURNE, Australia and INDIANAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 4:50 p.m. ET on Monday, September 8, 2025 (6:50 a.m. AEST, Sep 9) and at the H.C. Wainwright 27th Annual Global Investment Conference at 12:00 p.m. ET on Tuesday, September 9, 2025 (2:00 a.m. AEST, Sep 10).

Dr. Christian Behrenbruch, Managing Director and Group CEO, will participate in fireside chats at both conferences being held in New York (NY). Each session will be webcast live, and available on demand following the events.
[Source link]: https://www.globenewswire.com/news-release/2025/08/26/3139147/0/en/Telix-to-Present-at-the-Morgan-Stanley-23rd-Annual-Global-Healthcare-Conference-and-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html


[TITLE]Quantbot Technologies LP Invests $554,000 in Healthcare Services Group, Inc. $HCSG:
[TEXT]
Quantbot Technologies LP bought a new position in Healthcare Services Group, Inc. (NASDAQ:HCSG – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 54,967 shares of the business services provider’s stock, valued at approximately $554,000. Quantbot Technologies LP owned approximately 0.08% of Healthcare Services Group at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of HCSG. US Bancorp DE lifted its holdings in Healthcare Services Group by 161.4% during the 1st quarter. US Bancorp DE now owns 8,097 shares of the business services provider’s stock worth $82,000 after buying an additional 5,000 shares in the last quarter. PharVision Advisers LLC acquired a new position in Healthcare Services Group during the 4th quarter worth $147,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Healthcare Services Group by 45.3% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,592 shares of the business services provider’s stock worth $147,000 after buying an additional 4,548 shares in the last quarter. Dark Forest Capital Management LP acquired a new position in Healthcare Services Group during the 4th quarter worth $158,000. Finally, MQS Management LLC acquired a new position in Healthcare Services Group during the 1st quarter worth $173,000. Institutional investors and hedge funds own 97.97% of the company’s stock.

Get Healthcare Services Group alerts:

Wall Street Analysts Forecast Growth

HCSG has been the topic of several research reports. Macquarie raised Healthcare Services Group from a “neutral” rating to an “outperform” rating and upped their price objective for the stock from $15.00 to $16.00 in a report on Tuesday, July 29th. Benchmark upped their price objective on Healthcare Services Group from $17.00 to $19.00 and gave the stock a “buy” rating in a report on Thursday, July 24th. Wall Street Zen cut shares of Healthcare Services Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 26th. Robert W. Baird upped their target price on shares of Healthcare Services Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Thursday, July 24th. Finally, Zacks Research upgraded shares of Healthcare Services Group to a “strong-buy” rating in a research report on Tuesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, Healthcare Services Group has an average rating of “Buy” and a consensus target price of $16.25.

Insider Buying and Selling

In related news, EVP John Christopher Shea sold 21,368 shares of the firm’s stock in a transaction on Monday, July 28th. The stock was sold at an average price of $13.25, for a total transaction of $283,126.00. Following the sale, the executive vice president owned 32,976 shares of the company’s stock, valued at approximately $436,932. This trade represents a 39.32% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 2.10% of the company’s stock.

Healthcare Services Group Trading Down 1.8%

Shares of Healthcare Services Group stock opened at $15.49 on Tuesday. The company has a market capitalization of $1.12 billion, a PE ratio of 110.64 and a beta of 0.54. Healthcare Services Group, Inc. has a 12 month low of $9.13 and a 12 month high of $15.89. The stock’s fifty day simple moving average is $14.29 and its 200 day simple moving average is $12.81.

Healthcare Services Group (NASDAQ:HCSG – Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The business services provider reported $0.21 EPS for the quarter, topping the consensus estimate of $0.20 by $0.01. The business had revenue of $458.50 million for the quarter, compared to the consensus estimate of $450.78 million. Healthcare Services Group had a return on equity of 11.74% and a net margin of 0.61%.The firm’s revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.20 EPS. Healthcare Services Group has set its Q3 2025 guidance at EPS. Analysts predict that Healthcare Services Group, Inc. will post 0.74 EPS for the current fiscal year.
[Source link]: https://www.etfdailynews.com/2025/08/26/quantbot-technologies-lp-invests-554000-in-healthcare-services-group-inc-hcsg/

================================================================================

[TITLE]MedaSync announces strategic investment from Omega Healthcare OHI:
[TEXT]
Mon AS X AS Amer Sports

Block Trade

Managers: Morgan Stanley

Priced at: $39.90

4.05M Shares

Special Comments

Exclusive Analysis Locked Proprietary deal commentary available to members only.
[Source link]: https://thefly.com/permalinks/entry.php/id4189228/OHI-MedaSync-announces-strategic-investment-from-Omega-Healthcare


[TITLE]SCWorx Expands Healthcare Data Management Network with New Collaboration:
[TEXT]
Tampa, FL, Aug. 26, 2025 (GLOBE NEWSWIRE) -- SCWorx Corp. (Nasdaq: WORX) today announced a new agreement with a leading healthcare supply chain partner, further strengthening its SaaS data management program.

The partner is a recognized leader in healthcare supply chain consulting, with deep experience helping hospitals unlock cost savings and optimize spend management. The partner also has access to best-in-class products and services at the local, regional, and national levels for virtually every product or service to help hospitals optimize their direct and indirect procurement spend categories.

“This partner drives measurable savings by vetting vendors, analyzing contracts, and leveraging billions in spend through strategic purchasing. They have purchasing partners in all 50 states and are growing every day. All of this helps the partner anticipate, identify, and proactively deliver cost-saving opportunities through cooperative purchasing on an ongoing basis,” said Tim Hannibal, SCWorx CEO. Hannibal added, “The SCWorx Foundation product will help this partner enhance their product line and provide additional value to their healthcare customer. This partner chose SCWorx for its data cleanse, normalization and enrichment service offerings. SCWorx is a valuable data management service partner specifically built to help hospitals in the U.S. better utilize data. This partnership reinforces the unique value SCWorx delivers to hospitals nationwide.”
[Source link]: https://www.globenewswire.com/news-release/2025/08/26/3139426/0/en/SCWorx-Expands-Healthcare-Data-Management-Network-with-New-Collaboration.html


[TITLE]Quantbot Technologies LP Invests $554,000 in Healthcare Services Group, Inc. $HCSG:
[TEXT]
Quantbot Technologies LP bought a new position in Healthcare Services Group, Inc. (NASDAQ:HCSG – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 54,967 shares of the business services provider’s stock, valued at approximately $554,000. Quantbot Technologies LP owned approximately 0.08% of Healthcare Services Group at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of HCSG. US Bancorp DE lifted its holdings in Healthcare Services Group by 161.4% during the 1st quarter. US Bancorp DE now owns 8,097 shares of the business services provider’s stock worth $82,000 after buying an additional 5,000 shares in the last quarter. PharVision Advisers LLC acquired a new position in Healthcare Services Group during the 4th quarter worth $147,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Healthcare Services Group by 45.3% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,592 shares of the business services provider’s stock worth $147,000 after buying an additional 4,548 shares in the last quarter. Dark Forest Capital Management LP acquired a new position in Healthcare Services Group during the 4th quarter worth $158,000. Finally, MQS Management LLC acquired a new position in Healthcare Services Group during the 1st quarter worth $173,000. Institutional investors and hedge funds own 97.97% of the company’s stock.

Get Healthcare Services Group alerts:

Wall Street Analysts Forecast Growth

HCSG has been the topic of several research reports. Macquarie raised Healthcare Services Group from a “neutral” rating to an “outperform” rating and upped their price objective for the stock from $15.00 to $16.00 in a report on Tuesday, July 29th. Benchmark upped their price objective on Healthcare Services Group from $17.00 to $19.00 and gave the stock a “buy” rating in a report on Thursday, July 24th. Wall Street Zen cut shares of Healthcare Services Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 26th. Robert W. Baird upped their target price on shares of Healthcare Services Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Thursday, July 24th. Finally, Zacks Research upgraded shares of Healthcare Services Group to a “strong-buy” rating in a research report on Tuesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, Healthcare Services Group has an average rating of “Buy” and a consensus target price of $16.25.

Insider Buying and Selling

In related news, EVP John Christopher Shea sold 21,368 shares of the firm’s stock in a transaction on Monday, July 28th. The stock was sold at an average price of $13.25, for a total transaction of $283,126.00. Following the sale, the executive vice president owned 32,976 shares of the company’s stock, valued at approximately $436,932. This trade represents a 39.32% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 2.10% of the company’s stock.

Healthcare Services Group Trading Down 1.8%

Shares of Healthcare Services Group stock opened at $15.49 on Tuesday. The company has a market capitalization of $1.12 billion, a PE ratio of 110.64 and a beta of 0.54. Healthcare Services Group, Inc. has a 12 month low of $9.13 and a 12 month high of $15.89. The stock’s fifty day simple moving average is $14.29 and its 200 day simple moving average is $12.81.

Healthcare Services Group (NASDAQ:HCSG – Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The business services provider reported $0.21 EPS for the quarter, topping the consensus estimate of $0.20 by $0.01. The business had revenue of $458.50 million for the quarter, compared to the consensus estimate of $450.78 million. Healthcare Services Group had a return on equity of 11.74% and a net margin of 0.61%.The firm’s revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.20 EPS. Healthcare Services Group has set its Q3 2025 guidance at EPS. Analysts predict that Healthcare Services Group, Inc. will post 0.74 EPS for the current fiscal year.
[Source link]: https://www.etfdailynews.com/2025/08/26/quantbot-technologies-lp-invests-554000-in-healthcare-services-group-inc-hcsg/


[TITLE]Nuveen LLC Acquires New Holdings in Healthcare Services Group, Inc. $HCSG:
[TEXT]
Nuveen LLC acquired a new stake in Healthcare Services Group, Inc. (NASDAQ:HCSG – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 1,165,133 shares of the business services provider’s stock, valued at approximately $11,745,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Trail Ridge Investment Advisors LLC lifted its stake in Healthcare Services Group by 4.7% in the 1st quarter. Trail Ridge Investment Advisors LLC now owns 23,233 shares of the business services provider’s stock valued at $234,000 after purchasing an additional 1,048 shares during the last quarter. SummerHaven Investment Management LLC lifted its stake in Healthcare Services Group by 1.8% in the 1st quarter. SummerHaven Investment Management LLC now owns 73,841 shares of the business services provider’s stock valued at $744,000 after purchasing an additional 1,297 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Healthcare Services Group by 3.6% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 41,880 shares of the business services provider’s stock valued at $486,000 after acquiring an additional 1,461 shares during the period. North Star Investment Management Corp. increased its position in Healthcare Services Group by 1.8% in the 1st quarter. North Star Investment Management Corp. now owns 102,950 shares of the business services provider’s stock valued at $1,038,000 after acquiring an additional 1,850 shares during the period. Finally, Sterling Capital Management LLC increased its position in Healthcare Services Group by 803.4% in the 4th quarter. Sterling Capital Management LLC now owns 2,358 shares of the business services provider’s stock valued at $27,000 after acquiring an additional 2,097 shares during the period. Institutional investors own 97.97% of the company’s stock.

Get Healthcare Services Group alerts:

Healthcare Services Group Stock Up 3.6%

HCSG opened at $15.77 on Friday. Healthcare Services Group, Inc. has a twelve month low of $9.13 and a twelve month high of $15.80. The company has a fifty day moving average of $14.28 and a 200-day moving average of $12.75. The stock has a market cap of $1.14 billion, a PE ratio of 112.64 and a beta of 0.54.

Analyst Ratings Changes

Healthcare Services Group ( NASDAQ:HCSG Get Free Report ) last posted its quarterly earnings data on Wednesday, July 23rd. The business services provider reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01. Healthcare Services Group had a net margin of 0.61% and a return on equity of 11.74%. The company had revenue of $458.50 million during the quarter, compared to analysts’ expectations of $450.78 million. During the same period in the prior year, the company posted $0.20 earnings per share. Healthcare Services Group’s revenue for the quarter was up 7.6% compared to the same quarter last year. Healthcare Services Group has set its Q3 2025 guidance at EPS. Sell-side analysts anticipate that Healthcare Services Group, Inc. will post 0.74 EPS for the current fiscal year.

Several equities analysts have issued reports on the stock. Benchmark upped their price target on shares of Healthcare Services Group from $17.00 to $19.00 and gave the company a “buy” rating in a research report on Thursday, July 24th. Zacks Research upgraded shares of Healthcare Services Group to a “strong-buy” rating in a research report on Tuesday, August 12th. Robert W. Baird upped their price target on shares of Healthcare Services Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Thursday, July 24th. Macquarie upgraded shares of Healthcare Services Group from a “neutral” rating to an “outperform” rating and upped their price target for the company from $15.00 to $16.00 in a research report on Tuesday, July 29th. Finally, Wall Street Zen cut shares of Healthcare Services Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 26th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $16.25.

View Our Latest Analysis on HCSG

Insider Buying and Selling at Healthcare Services Group

In other news, EVP John Christopher Shea sold 21,368 shares of the stock in a transaction on Monday, July 28th. The shares were sold at an average price of $13.25, for a total transaction of $283,126.00. Following the completion of the sale, the executive vice president directly owned 32,976 shares in the company, valued at $436,932. This represents a 39.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 2.60% of the stock is currently owned by company insiders.

Healthcare Services Group Company Profile

(Free Report)

Healthcare Services Group, Inc provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. It operates through two segments, Housekeeping and Dietary.

Further Reading

Want to see what other hedge funds are holding HCSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthcare Services Group, Inc. (NASDAQ:HCSG – Free Report).

Receive News & Ratings for Healthcare Services Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Services Group and related companies with MarketBeat.com's FREE daily email newsletter.
[Source link]: https://www.etfdailynews.com/2025/08/23/nuveen-llc-acquires-new-holdings-in-healthcare-services-group-inc-hcsg/

================================================================================

[TITLE]HighTower Advisors LLC Acquires 37,361 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR:
[TEXT]
HighTower Advisors LLC lifted its holdings in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 49.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 112,417 shares of the biotechnology company’s stock after purchasing an additional 37,361 shares during the quarter. HighTower Advisors LLC’s holdings in Arrowhead Pharmaceuticals were worth $1,432,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the business. Public Sector Pension Investment Board bought a new position in shares of Arrowhead Pharmaceuticals during the first quarter worth approximately $5,094,000. Nuveen LLC bought a new position in Arrowhead Pharmaceuticals in the first quarter valued at approximately $4,305,000. King Luther Capital Management Corp increased its stake in Arrowhead Pharmaceuticals by 8.6% in the first quarter. King Luther Capital Management Corp now owns 83,590 shares of the biotechnology company’s stock valued at $1,065,000 after acquiring an additional 6,625 shares during the last quarter. Invesco Ltd. increased its stake in Arrowhead Pharmaceuticals by 78.2% in the first quarter. Invesco Ltd. now owns 314,080 shares of the biotechnology company’s stock valued at $4,001,000 after acquiring an additional 137,845 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Arrowhead Pharmaceuticals by 9.0% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 14,476 shares of the biotechnology company’s stock valued at $184,000 after acquiring an additional 1,195 shares during the last quarter. 62.61% of the stock is owned by institutional investors.

Get Arrowhead Pharmaceuticals alerts:

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on ARWR shares. TD Cowen raised shares of Arrowhead Pharmaceuticals to a “strong-buy” rating in a research note on Monday, July 28th. Citigroup decreased their price objective on shares of Arrowhead Pharmaceuticals from $21.00 to $17.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 13th. Wall Street Zen cut shares of Arrowhead Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Friday, July 18th. Chardan Capital reissued a “buy” rating and issued a $60.00 price objective on shares of Arrowhead Pharmaceuticals in a research note on Monday, August 11th. Finally, Royal Bank Of Canada decreased their price objective on shares of Arrowhead Pharmaceuticals from $40.00 to $38.00 and set an “outperform” rating on the stock in a research note on Friday, August 8th. Two analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, Arrowhead Pharmaceuticals has an average rating of “Buy” and a consensus target price of $43.14.

Arrowhead Pharmaceuticals Stock Performance

Shares of Arrowhead Pharmaceuticals stock opened at $20.71 on Tuesday. Arrowhead Pharmaceuticals, Inc. has a fifty-two week low of $9.57 and a fifty-two week high of $27.34. The company has a debt-to-equity ratio of 0.39, a current ratio of 4.87 and a quick ratio of 4.87. The firm has a market capitalization of $2.86 billion, a P/E ratio of -16.18 and a beta of 0.94. The company’s 50 day moving average price is $17.20 and its two-hundred day moving average price is $15.90.

Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) last issued its earnings results on Thursday, August 7th. The biotechnology company reported ($1.26) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.94) by ($0.32). The business had revenue of $27.77 million for the quarter, compared to analysts’ expectations of $29.01 million. During the same quarter in the prior year, the company earned ($1.38) EPS. On average, equities analysts forecast that Arrowhead Pharmaceuticals, Inc. will post -2.42 earnings per share for the current fiscal year.

Insider Activity at Arrowhead Pharmaceuticals

In other news, insider James C. Hamilton sold 9,389 shares of Arrowhead Pharmaceuticals stock in a transaction on Friday, August 15th. The shares were sold at an average price of $20.00, for a total transaction of $187,780.00. Following the transaction, the insider owned 262,122 shares in the company, valued at approximately $5,242,440. The trade was a 3.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 4.30% of the company’s stock.
[Source link]: https://www.etfdailynews.com/2025/08/26/hightower-advisors-llc-acquires-37361-shares-of-arrowhead-pharmaceuticals-inc-arwr/


[TITLE]AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline:
[TEXT]
NORTH CHICAGO, Ill. and NEW YORK, Aug. 25, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Gilgamesh Pharmaceuticals Inc. ("Gilgamesh") today announced a definitive agreement under which AbbVie will acquire Gilgamesh's lead investigational candidate, currently in clinical development for the…

This story appeared on news.abbvie.com , 2025-08-25 14:52:27.963000.
[Source link]: https://biztoc.com/x/f90a0380efe821c8


[TITLE]American Century Companies Inc. Increases Stake in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA:
[TEXT]
American Century Companies Inc. boosted its position in shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA – Free Report) by 1.2% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 1,092,754 shares of the company’s stock after purchasing an additional 13,046 shares during the quarter. American Century Companies Inc.’s holdings in Centessa Pharmaceuticals were worth $15,714,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CNTA. Janus Henderson Group PLC grew its position in Centessa Pharmaceuticals by 279.2% during the 4th quarter. Janus Henderson Group PLC now owns 4,909,487 shares of the company’s stock valued at $82,218,000 after purchasing an additional 3,614,623 shares during the last quarter. Foresite Capital Management VI LLC purchased a new stake in Centessa Pharmaceuticals during the 4th quarter valued at
[Source link]: https://www.etfdailynews.com/2025/08/25/american-century-companies-inc-increases-stake-in-centessa-pharmaceuticals-plc-sponsored-adr-cnta/


[TITLE]Charles Schwab Investment Management Inc. Boosts Stock Position in Recursion Pharmaceuticals, Inc. $RXRX:
[TEXT]
Charles Schwab Investment Management Inc. lifted its holdings in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 0.2% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 2,278,401 shares of the company’s stock after purchasing an additional 4,398 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Recursion Pharmaceuticals were worth $12,053,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Softbank Group CORP. acquired a new stake in shares of Recursion Pharmaceuticals during the fourth quarter worth $99,152,000. Novo Holdings A S purchased a new position in Recursion Pharmaceuticals in the fourth quarter valued at
[Source link]: https://www.etfdailynews.com/2025/08/25/charles-schwab-investment-management-inc-boosts-stock-position-in-recursion-pharmaceuticals-inc-rxrx/

================================================================================

[TITLE]Brooklyn Investment Group Makes New Investment in Sana Biotechnology, Inc. $SANA:
[TEXT]
Brooklyn Investment Group purchased a new position in shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) during the first quarter, Holdings Channel.com reports. The firm purchased 25,943 shares of the company’s stock, valued at approximately $44,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of SANA. Geode Capital Management LLC boosted its holdings in shares of Sana Biotechnology by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 3,193,081 shares of the company’s stock worth $5,206,000 after buying an additional 26,601 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in shares of Sana Biotechnology by 51.0% during the 4th quarter. Wells Fargo & Company MN now owns 62,021 shares of the company’s stock worth $101,000 after buying an additional 20,950 shares in the last quarter. Cerity Partners LLC bought a new position in shares of Sana Biotechnology during the 4th quarter worth approximately $25,000. Renaissance Technologies LLC boosted its holdings in shares of Sana Biotechnology by 1,838.3% during the 4th quarter. Renaissance Technologies LLC now owns 319,818 shares of the company’s stock worth $521,000 after buying an additional 303,318 shares in the last quarter. Finally, Walleye Capital LLC bought a new position in shares of Sana Biotechnology during the 4th quarter worth approximately $152,000. 88.23% of the stock is currently owned by institutional investors.

Get Sana Biotechnology alerts:

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on SANA. JMP Securities reiterated a “market outperform” rating and issued a $5.00 target price on shares of Sana Biotechnology in a report on Tuesday, June 24th. Morgan Stanley began coverage on Sana Biotechnology in a report on Thursday, July 3rd. They issued an “overweight” rating and a $12.00 target price on the stock. Six research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $8.00.

Sana Biotechnology Stock Down 0.6%

Shares of SANA opened at $3.58 on Friday. Sana Biotechnology, Inc. has a 12-month low of $1.26 and a 12-month high of $7.30. The business’s fifty day moving average is $3.64 and its 200 day moving average is $2.70. The stock has a market cap of $851.36 million, a P/E ratio of -3.38 and a beta of 1.90.

Sana Biotechnology (NASDAQ:SANA – Get Free Report) last released its quarterly earnings results on Monday, August 11th. The company reported ($0.16) EPS for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.04. On average, analysts expect that Sana Biotechnology, Inc. will post -1.16 EPS for the current year.
[Source link]: https://www.etfdailynews.com/2025/08/24/brooklyn-investment-group-makes-new-investment-in-sana-biotechnology-inc-sana/


[TITLE]Vanguard Group Inc. Reduces Stake in Vir Biotechnology, Inc. $VIR:
[TEXT]
Vanguard Group Inc. lessened its position in shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 2.5% in the first quarter, Holdings Channel reports. The fund owned 12,807,508 shares of the company’s stock after selling 323,127 shares during the quarter. Vanguard Group Inc. owned
[Source link]: https://www.etfdailynews.com/2025/08/24/vanguard-group-inc-reduces-stake-in-vir-biotechnology-inc-vir/

================================================================================

[TITLE]SCWorx Expands Healthcare Data Management Network with New Collaboration:
[TEXT]
Tampa, FL, Aug. 26, 2025 (GLOBE NEWSWIRE) -- SCWorx Corp. (Nasdaq: WORX) today announced a new agreement with a leading healthcare supply chain partner, further strengthening its SaaS data management program.

The partner is a recognized leader in healthcare supply chain consulting, with deep experience helping hospitals unlock cost savings and optimize spend management. The partner also has access to best-in-class products and services at the local, regional, and national levels for virtually every product or service to help hospitals optimize their direct and indirect procurement spend categories.

“This partner drives measurable savings by vetting vendors, analyzing contracts, and leveraging billions in spend through strategic purchasing. They have purchasing partners in all 50 states and are growing every day. All of this helps the partner anticipate, identify, and proactively deliver cost-saving opportunities through cooperative purchasing on an ongoing basis,” said Tim Hannibal, SCWorx CEO. Hannibal added, “The SCWorx Foundation product will help this partner enhance their product line and provide additional value to their healthcare customer. This partner chose SCWorx for its data cleanse, normalization and enrichment service offerings. SCWorx is a valuable data management service partner specifically built to help hospitals in the U.S. better utilize data. This partnership reinforces the unique value SCWorx delivers to hospitals nationwide.”
[Source link]: https://www.globenewswire.com/news-release/2025/08/26/3139426/0/en/SCWorx-Expands-Healthcare-Data-Management-Network-with-New-Collaboration.html


[TITLE]Telix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference:
[TEXT]
MELBOURNE, Australia and INDIANAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 4:50 p.m. ET on Monday, September 8, 2025 (6:50 a.m. AEST, Sep 9) and at the H.C. Wainwright 27th Annual Global Investment Conference at 12:00 p.m. ET on Tuesday, September 9, 2025 (2:00 a.m. AEST, Sep 10).

Dr. Christian Behrenbruch, Managing Director and Group CEO, will participate in fireside chats at both conferences being held in New York (NY). Each session will be webcast live, and available on demand following the events.
[Source link]: https://www.globenewswire.com/news-release/2025/08/26/3139147/0/en/Telix-to-Present-at-the-Morgan-Stanley-23rd-Annual-Global-Healthcare-Conference-and-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html


[TITLE]Quantbot Technologies LP Invests $554,000 in Healthcare Services Group, Inc. $HCSG:
[TEXT]
Quantbot Technologies LP bought a new position in Healthcare Services Group, Inc. (NASDAQ:HCSG – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 54,967 shares of the business services provider’s stock, valued at approximately $554,000. Quantbot Technologies LP owned approximately 0.08% of Healthcare Services Group at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of HCSG. US Bancorp DE lifted its holdings in Healthcare Services Group by 161.4% during the 1st quarter. US Bancorp DE now owns 8,097 shares of the business services provider’s stock worth $82,000 after buying an additional 5,000 shares in the last quarter. PharVision Advisers LLC acquired a new position in Healthcare Services Group during the 4th quarter worth $147,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Healthcare Services Group by 45.3% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,592 shares of the business services provider’s stock worth $147,000 after buying an additional 4,548 shares in the last quarter. Dark Forest Capital Management LP acquired a new position in Healthcare Services Group during the 4th quarter worth $158,000. Finally, MQS Management LLC acquired a new position in Healthcare Services Group during the 1st quarter worth $173,000. Institutional investors and hedge funds own 97.97% of the company’s stock.

Get Healthcare Services Group alerts:

Wall Street Analysts Forecast Growth

HCSG has been the topic of several research reports. Macquarie raised Healthcare Services Group from a “neutral” rating to an “outperform” rating and upped their price objective for the stock from $15.00 to $16.00 in a report on Tuesday, July 29th. Benchmark upped their price objective on Healthcare Services Group from $17.00 to $19.00 and gave the stock a “buy” rating in a report on Thursday, July 24th. Wall Street Zen cut shares of Healthcare Services Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 26th. Robert W. Baird upped their target price on shares of Healthcare Services Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Thursday, July 24th. Finally, Zacks Research upgraded shares of Healthcare Services Group to a “strong-buy” rating in a research report on Tuesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, Healthcare Services Group has an average rating of “Buy” and a consensus target price of $16.25.

Insider Buying and Selling

In related news, EVP John Christopher Shea sold 21,368 shares of the firm’s stock in a transaction on Monday, July 28th. The stock was sold at an average price of $13.25, for a total transaction of $283,126.00. Following the sale, the executive vice president owned 32,976 shares of the company’s stock, valued at approximately $436,932. This trade represents a 39.32% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 2.10% of the company’s stock.

Healthcare Services Group Trading Down 1.8%

Shares of Healthcare Services Group stock opened at $15.49 on Tuesday. The company has a market capitalization of $1.12 billion, a PE ratio of 110.64 and a beta of 0.54. Healthcare Services Group, Inc. has a 12 month low of $9.13 and a 12 month high of $15.89. The stock’s fifty day simple moving average is $14.29 and its 200 day simple moving average is $12.81.

Healthcare Services Group (NASDAQ:HCSG – Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The business services provider reported $0.21 EPS for the quarter, topping the consensus estimate of $0.20 by $0.01. The business had revenue of $458.50 million for the quarter, compared to the consensus estimate of $450.78 million. Healthcare Services Group had a return on equity of 11.74% and a net margin of 0.61%.The firm’s revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.20 EPS. Healthcare Services Group has set its Q3 2025 guidance at EPS. Analysts predict that Healthcare Services Group, Inc. will post 0.74 EPS for the current fiscal year.
[Source link]: https://www.etfdailynews.com/2025/08/26/quantbot-technologies-lp-invests-554000-in-healthcare-services-group-inc-hcsg/


[TITLE]Nuveen LLC Acquires New Holdings in Healthcare Services Group, Inc. $HCSG:
[TEXT]
Nuveen LLC acquired a new stake in Healthcare Services Group, Inc. (NASDAQ:HCSG – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 1,165,133 shares of the business services provider’s stock, valued at approximately $11,745,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Trail Ridge Investment Advisors LLC lifted its stake in Healthcare Services Group by 4.7% in the 1st quarter. Trail Ridge Investment Advisors LLC now owns 23,233 shares of the business services provider’s stock valued at $234,000 after purchasing an additional 1,048 shares during the last quarter. SummerHaven Investment Management LLC lifted its stake in Healthcare Services Group by 1.8% in the 1st quarter. SummerHaven Investment Management LLC now owns 73,841 shares of the business services provider’s stock valued at $744,000 after purchasing an additional 1,297 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Healthcare Services Group by 3.6% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 41,880 shares of the business services provider’s stock valued at $486,000 after acquiring an additional 1,461 shares during the period. North Star Investment Management Corp. increased its position in Healthcare Services Group by 1.8% in the 1st quarter. North Star Investment Management Corp. now owns 102,950 shares of the business services provider’s stock valued at $1,038,000 after acquiring an additional 1,850 shares during the period. Finally, Sterling Capital Management LLC increased its position in Healthcare Services Group by 803.4% in the 4th quarter. Sterling Capital Management LLC now owns 2,358 shares of the business services provider’s stock valued at $27,000 after acquiring an additional 2,097 shares during the period. Institutional investors own 97.97% of the company’s stock.

Get Healthcare Services Group alerts:

Healthcare Services Group Stock Up 3.6%

HCSG opened at $15.77 on Friday. Healthcare Services Group, Inc. has a twelve month low of $9.13 and a twelve month high of $15.80. The company has a fifty day moving average of $14.28 and a 200-day moving average of $12.75. The stock has a market cap of $1.14 billion, a PE ratio of 112.64 and a beta of 0.54.

Analyst Ratings Changes

Healthcare Services Group ( NASDAQ:HCSG Get Free Report ) last posted its quarterly earnings data on Wednesday, July 23rd. The business services provider reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01. Healthcare Services Group had a net margin of 0.61% and a return on equity of 11.74%. The company had revenue of $458.50 million during the quarter, compared to analysts’ expectations of $450.78 million. During the same period in the prior year, the company posted $0.20 earnings per share. Healthcare Services Group’s revenue for the quarter was up 7.6% compared to the same quarter last year. Healthcare Services Group has set its Q3 2025 guidance at EPS. Sell-side analysts anticipate that Healthcare Services Group, Inc. will post 0.74 EPS for the current fiscal year.

Several equities analysts have issued reports on the stock. Benchmark upped their price target on shares of Healthcare Services Group from $17.00 to $19.00 and gave the company a “buy” rating in a research report on Thursday, July 24th. Zacks Research upgraded shares of Healthcare Services Group to a “strong-buy” rating in a research report on Tuesday, August 12th. Robert W. Baird upped their price target on shares of Healthcare Services Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Thursday, July 24th. Macquarie upgraded shares of Healthcare Services Group from a “neutral” rating to an “outperform” rating and upped their price target for the company from $15.00 to $16.00 in a research report on Tuesday, July 29th. Finally, Wall Street Zen cut shares of Healthcare Services Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 26th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $16.25.

View Our Latest Analysis on HCSG

Insider Buying and Selling at Healthcare Services Group

In other news, EVP John Christopher Shea sold 21,368 shares of the stock in a transaction on Monday, July 28th. The shares were sold at an average price of $13.25, for a total transaction of $283,126.00. Following the completion of the sale, the executive vice president directly owned 32,976 shares in the company, valued at $436,932. This represents a 39.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 2.60% of the stock is currently owned by company insiders.

Healthcare Services Group Company Profile

(Free Report)

Healthcare Services Group, Inc provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. It operates through two segments, Housekeeping and Dietary.

Further Reading

Want to see what other hedge funds are holding HCSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthcare Services Group, Inc. (NASDAQ:HCSG – Free Report).

Receive News & Ratings for Healthcare Services Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Services Group and related companies with MarketBeat.com's FREE daily email newsletter.
[Source link]: https://www.etfdailynews.com/2025/08/23/nuveen-llc-acquires-new-holdings-in-healthcare-services-group-inc-hcsg/

================================================================================

